IDXX (IDEXX Laboratories, Inc.) Stock Financials & Earnings

IDXXIDEXX Laboratories, Inc.

Mkt Cap$48B

Revenue (TTM)$4.3B

Net Income (TTM)$1.1B

EPS (TTM)$13.07

Free Cash Flow (TTM)$1.1B

Gross Margin61.8%

Op. Margin31.6%

Net Margin24.6%

FCF Margin24.5%

P/S Ratio (TTM)11.3x

P/E Ratio (TTM)45.8x

YoY Rev Growth+10.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$900M	$543M	$280M
Q2 23	$944M	$573M	$296M
Q3 23	$916M	$548M	$275M
Q4 23	$902M	$526M	$245M
Q1 24	$964M	$593M	$299M
Q2 24	$1.0B	$621M	$264M
Q3 24	$976M	$596M	$304M
Q4 24	$954M	$571M	$262M
Q1 25	$998M	$623M	$317M
Q2 25	$1.1B	$695M	$373M
Q3 25	$1.1B	$683M	$355M
Q4 25	$1.1B	$658M	$316M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$45M	$70M	$148M
Q2 23	$47M	$90M	$141M
Q3 23	$48M	$89M	$136M
Q4 23	$52M	$87M	$142M
Q1 24	$53M	$92M	$149M
Q2 24	$55M	$157M	$143M
Q3 24	$54M	$92M	$146M
Q4 24	$58M	$101M	$150M
Q1 25	$59M	$92M	$156M
Q2 25	$62M	$99M	$161M
Q3 25	$63M	$106M	$159M
Q4 25	$67M	$109M	$167M

Revenue Segments

Revenue by Geography

Quarter	Asia Pacific	Canada	Emea	Latin America	United States
Q1 23	$78M	$36M	$176M	$19M	$590M
Q2 23	$81M	$42M	$179M	$21M	$622M
Q3 23	$78M	$36M	$178M	$21M	$603M
Q1 24	$76M	$37M	$200M	$20M	$631M
Q2 24	$80M	$41M	$201M	$21M	$660M
Q3 24	$81M	$37M	$199M	$21M	$638M
Q4 24	$83M	$38M	$208M	$21M	$604M
Q1 25	$82M	$37M	$205M	—	$655M
Q2 25	$89M	$47M	$233M	$22M	$718M
Q3 25	$91M	$41M	$245M	$23M	$705M
Q4 25	$94M	$42M	$254M	$45M	$675M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$111M	$0	$111M
Q2 23	$133M	$0	$133M
Q3 23	$332M	$0	$332M
Q4 23	$454M	$0	$454M
Q1 24	$397M	$0	$397M
Q2 24	$402M	$0	$402M
Q3 24	$309M	$0	$309M
Q4 24	$288M	$0	$288M
Q1 25	$164M	$0	$164M
Q2 25	$165M	$0	$165M
Q3 25	$208M	$0	$208M
Q4 25	$180M	$0	$180M

Shares Outstanding

Revenue Per Employee

Revenue / Employee